Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: Tiapride vs. pyridostigmine

Toxicology and Applied Pharmacology

Volumn 219, Issue 2-3, 2007, Pages 235-240

  Petroianu, G A ^a   Hasan, M Y ^a   Nurulain, S M ^a   Arafat, K ^a   Sheen, R ^a   Nagelkerke, N ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cholinesterase; Organophosphate; Paraoxon; Pyridostigmine; Tiapride; Treatment

Indexed keywords

ORGANOPHOSPHATE; PARAOXON; PYRIDOSTIGMINE; TIAPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTOXICATION; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; MORTALITY; NONHUMAN; PROSPECTIVE STUDY; RAT; SPECIES DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL TIME; WISTAR RAT;

ACUTE DISEASE; ANIMALS; BINDING, COMPETITIVE; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; PARAOXON; POISONING; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR; TIAPRIDE;

RATTUS;

EID: 33847146245     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.09.002     Document Type: Article

References (34)

1. Bartling A., Thiermann H., Szinicz L., and Worek F. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro. J. Appl. Toxicol. 25 (2005) 568-571
2. Dart R.C., Goldfrank L.R., Chyka P.A., Lotzer D., Woolf A.D., McNally J., Snodgrass W.R., Olson K.R., Scharman E., Geller R.J., Spyker D., Kraft M., and Lipsy R. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med 36 (2000) 126-132
3. Dawson J.D., and Lagakos S.W. Size and power of two sampled tests of repeated measures data. Biometrics 49 (1993) 1022-1032
4. Delmeire F. Tiapridal. Acta Psychiatr. Belg. 80 (1980) 191-201
5. Dunn M.A., Hackley B.E., and Sidell F.R. Pretreatment for nerve agent exposure. In: Sidell F.R., Takafuji E.T., and Franz D.R. (Eds). Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Washington, DC (1997), Borden Institute, Walter Reed Army Medical Center 181-196
6. Ellman G.L., Courtney K.D., Feather-Stone R.M., and Andres Jr. V. A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
7. Fontaine J., and Reuse J. The effects of substituted benzamides on frog rectus abdominis. Eur. J. Pharmacol. 68 (1980) 55-60
8. Gordon J.J., Leadbeater L., and Maidment M.P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43 (1978) 207-216
9. Hasan M.Y., Nurulain S.M., Arafat K., Naseer O.P., and Petroianu G.A. In-vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in sub-chronic low dose exposure. J. Appl. Toxicol. 24 (2004) 257-260
10. Jeyaratnam J. Acute pesticide poisoning: a major global health problem. World Health Stat. Q 43 (1990) 139-144
11. Johnson M.K., Jacobsen D., Meredith T.J., Eyer P., Heath A.J., Ligtenstein D.A., and Marrs T.C. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg. Med. 12 (2000) 22-37
12. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
13. Levine R. Recognized and possible effects of pesticides in humans. In: Hayes W.J., and Laws E.R. (Eds). Handbook of Pesticide Toxicology, General Principles vol. 1 (1991), Academic Press, San Diego 275-360
14. Marino M.T., Schuster B.G., Brueckner R.P., Lin E., Kaminskis A., and Lasseter K.C. Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol. 38 (1998) 227-235
15. Namba T. Cholinesterase inhibition by organophosphorus compounds, and its clinical effects. Bull. WHO 44 (1971) 289-307
16. Namba T., Nolte C.T., Jackrel J., and Grob D. Poisoning due to organophosphate insecticides: acute and chronic manifestations. Am. J. Med. 50 (1971) 457-492
17. Nostrandt A.C., Duncan J.A., and Padilla S. A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 21 (1993) 196-203
18. Peter J.V., and Cherian A.M. Organic insecticides. Anaesth. Intensive Care 28 (2000) 11-21
19. Petroianu G., Toomes L.M., Petroianu A., Bergler W., and Rufer R. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 18 (1998) 293-298
20. Petroianu G., Arafat K., Kosanovic M., Saleh A., Camasamudram V., and Hassan M.Y. In vitro protection of RBC acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). J. Appl. Toxicol. 23 (2003) 447-451
21. Petroianu G.A., Arafat K., Schmitt A., and Hasan M.Y. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine. J. Appl. Toxicol. 25 (2005) 60-67
22. Petroianu G.A., Hasan M.Y., Nurulain S.M., Arafat K., Shafiullah M., and Naseer O.P. Protective agents in acute high dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. J. Appl. Toxicol. 25 (2005) 68-73
23. Petroianu G.A., Arafat K., Schmitt A., and Hasan M.Y. Weak inhibitors protect cholinesterases from strong inhibitors (dichlorvos): in vitro effect of tiapride. Int. J. Toxicol. 24 (2005) 79-86
24. Petroianu G.A., Hasan M.Y., Nurulain S.M., Arafat K., Sheen R., Saleh A., and Schmitt A. Protective agents in acute high dose exposure to organophosphates: comparison of metoclopramide and tiapride with pralidoxime in rats. Anesth. Analg. 100 (2005) 382-386
25. Petroianu G.A., Hasan M.Y., Nurulain S.M., Arafat K., Shafiullah M., and Sheen R. Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats. Cell. Moll. Biochem. 285 (2006) 79-86
26. Petroianu G.A., Nurulain S.M., Arafat K., Sheen R., and Hasan M.Y. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. Arch. Toxicol. (2006) (Electronic publication ahead of print)
27. Satoh H., Nakanishi H., Shirakawa K., Kohjimoto Y., Kuwaki T., Ono T., and Shibayama F. Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizure in mice. Jpn. J. Pharmacol. 43 (1987) 27-32
28. Thompson C.M., and Richardson R.J. Anticholinesterase insecticides. In: Marrs T.C., and Ballantyne B. (Eds). Pesticide Toxicology and International Regulation (Current Toxicology Series) (2004), John Wiley and Sons Ltd., Chichester 89-127
29. van Helden H.P., Busker R.W., Melchers B.P., and Bruijnzeel P.L. Pharmacological effects of oximes: how relevant are they?. Arch. Toxicol. 70 (1996) 779-786
30. van Kampen E.J., and Zijlstra W.G. Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin. Chim. Acta 6 (1961) 538-544
31. Warter J.M., Vergnes M., Depaulis A., Tranchant C., Rumbach L., Micheletti G., and Marescaux C. Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology 27 (1988) 269-274
32. Wiener S.W., and Hoffman R.S. Nerve agents: a comprehensive review. J. Int. Care Med. 19 (2004) 22-37
33. Worek F., Mast U., Kiderlen D., Diepold C., and Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin. Chim. Acta 288 (1999) 73-90
34. Zoch E. Die Wirkung organischer phosphorsäureester bzw. Phosphorsäureester auf versch. Enzyme. Arzneim. Forschung. 21 (1971) 181-187